|
|
|
|
|
|
by najarvg
972 days ago
|
|
|
Most therapeutic trials are nowadays "Intent to treat". So subject would receive either standardized tx or experimental tx in th e randomization. Many of them also have crossovers such that when measurable (as defined by the protocol) benefit is seen, standard tx based subjects can be moved over to the experimental arm |
|
|